Arcturus Therapeutics Holdings Inc (ARCT) - Total Liabilities

Latest as of December 2025: $57.16 Million USD

Based on the latest financial reports, Arcturus Therapeutics Holdings Inc (ARCT) has total liabilities worth $57.16 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore ARCT cash flow conversion to assess how effectively this company generates cash.

Arcturus Therapeutics Holdings Inc - Total Liabilities Trend (2011–2025)

This chart illustrates how Arcturus Therapeutics Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. Check ARCT asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Arcturus Therapeutics Holdings Inc Competitors by Total Liabilities

The table below lists competitors of Arcturus Therapeutics Holdings Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Mahanagar Telephone Nigam Limited NSE:MTNL	India	Rs383.47 Billion
BYC Co. Ltd KO:001460	Korea	₩176.08 Billion
KNJ Co. Ltd KQ:272110	Korea	₩68.12 Billion
Immersion Corporation NASDAQ:IMMR	USA	$804.25 Million
Kuo Yang Construction Co Ltd TW:2505	Taiwan	NT$11.65 Billion
Kreditbanken A/S CO:KRE	Denmark	Dkr6.15 Billion
High Tide Inc V:HITI	Canada	CA$244.43 Million
Gemini Space Station, Inc. Class A Common Stock NASDAQ:GEMI	USA	$1.27 Billion

Liability Composition Analysis (2011–2025)

This chart breaks down Arcturus Therapeutics Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Arcturus Therapeutics Holdings Inc market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	6.64	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.27	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.21	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Arcturus Therapeutics Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Arcturus Therapeutics Holdings Inc (2011–2025)

The table below shows the annual total liabilities of Arcturus Therapeutics Holdings Inc from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	$57.16 Million	-44.55%
2024-12-31	$103.09 Million	-31.68%
2023-12-31	$150.89 Million	-16.21%
2022-12-31	$180.07 Million	+9.40%
2021-12-31	$164.60 Million	+106.00%
2020-12-31	$79.90 Million	+41.80%
2019-12-31	$56.35 Million	+84.42%
2018-12-31	$30.56 Million	+67.61%
2017-12-31	$18.23 Million	+320.05%
2016-12-31	$4.34 Million	+84.52%
2015-12-31	$2.35 Million	-0.97%
2014-12-31	$2.38 Million	+45.17%
2013-12-31	$1.64 Million	+113.02%
2012-12-31	$768.00K	+250.68%
2011-12-31	$219.00K	--

About Arcturus Therapeutics Holdings Inc

NASDAQ:ARCT USA Biotechnology

Market Cap

$245.29 Million

Market Cap Rank

#16315 Global

#3685 in USA

Share Price

$8.63

Change (1 day)

+0.12%

52-Week Range

$5.90 - $23.16

All Time High

$123.66